View Single Post
Old 10-19-2013, 08:10 PM   #1
Senior Member
'lizbeth's Avatar
Join Date: Apr 2008
Location: Sunny San Diego
Posts: 2,214
Post Cabergoline in Metastatic Breast Cancer

Cabergoline in Metastatic Breast Cancer

This study is currently recruiting participants.
Verified September 2013 by Northwestern University
Northwestern University
Lynn Sage Foundation
Information provided by (Responsible Party):
Northwestern University Identifier:
First received: November 15, 2012
Last updated: September 17, 2013
Last verified: September 2013
History of Changes

Purpose Prolactin is a hormone produced in the pituitary gland. Previous studies have revealed that elevated levels of the hormone prolactin might be associated with an increased risk of breast cancer. Cabergoline has been shown to lower prolactin levels in the blood.
The purpose of this study is to evaluate the effectiveness of cabergoline in treating metastatic breast cancer disease in those who test positive for the prolactin receptor.
'lizbeth is offline   Reply With Quote